1-3 of 3
Evan C. Chen
Close
Sort by
Journal Articles

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era

Anand A Patel, James J. Yoon, Hannah Johnston, Marta B. Davidson, Rory M. Shallis, Evan C. Chen, Madelyn Burkart, Timothy S. Oh, Sunil Girish Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero-Marroquin, Raajit K. Rampal, Guru Subramanian Guru Murthy, Terrence J Bradley, Yasmin Abaza, Jacqueline S. Garcia, Vikas Gupta, Kristen M. Pettit, John F. Cursio, Olatoyosi Odenike
Journal: Blood Advances
Blood Adv bloodadvances.2024012880.
https://doi.org/10.1182/bloodadvances.2024012880
Published: 2024
Includes: Supplemental data
Journal Articles

FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years

Clinical Trials & Observations
Shai Shimony, Geoffrey Fell, Evan C. Chen, Harrison K. Tsai, Martha Wadleigh, Eric S. Winer, Jacqueline S. Garcia, Marlise R. Luskin, Maximilian Stahl, Donna S. Neuberg, Daniel J. DeAngelo, R. Coleman Lindsley, Richard M. Stone
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5354–5358.
https://doi.org/10.1182/bloodadvances.2023009748
Published: 2023
Includes: Supplemental data
Journal Articles

Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization

Clinical Trials & Observations
Megan Mullins, Xiaohui Jiang, Lauren C. Bylsma, Jon P. Fryzek, Heidi Reichert, Evan C. Chen, Shivaani Kummar, Adam Rosenthal
Journal: Blood Advances
Blood Adv (2017) 1 (13): 839–848.
https://doi.org/10.1182/bloodadvances.2017004390
Published: 2017
Includes: Supplemental data